Tokyo, Japan

Kengo Sugahara

USPTO Granted Patents = 12 


 

Average Co-Inventor Count = 3.3

ph-index = 3

Forward Citations = 65(Granted Patents)


Location History:

  • Chiyoda-ku, JP (2014 - 2016)
  • Tokyo, JP (2013 - 2018)

Company Filing History:


Years Active: 2013-2018

Loading Chart...
Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: Kengo Sugahara: Innovator in Particle Acceleration Technology

Introduction

Kengo Sugahara is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of particle acceleration technology, holding a total of 12 patents. His work focuses on enhancing the efficiency and effectiveness of particle-beam therapy devices and circular accelerators.

Latest Patents

Among his latest patents are innovations such as a circular accelerator and a particle-beam therapy device. The circular accelerator is designed to accelerate charged particles along a predetermined orbital path. It features a multipole electromagnet energization control unit that allows for the extraction of charged particles while discarding unwanted particles. The particle-beam therapy device includes a controller that manages the operation of acceleration-related and extraction-related devices, ensuring precise timing and energy levels for effective particle beam therapy.

Career Highlights

Kengo Sugahara has worked with leading companies in the technology sector, including Mitsubishi Electric Corporation and Hitachi, Ltd. His experience in these organizations has allowed him to develop and refine his innovative ideas in particle acceleration.

Collaborations

Throughout his career, Sugahara has collaborated with notable colleagues such as Shuhei Odawara and Kazushi Hanakawa. These partnerships have contributed to the advancement of his research and the successful implementation of his inventions.

Conclusion

Kengo Sugahara's contributions to particle acceleration technology have positioned him as a key figure in the field. His innovative patents and collaborations reflect his commitment to advancing technology for therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…